BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30664566)

  • 1. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey.
    Bronsky J; de Ridder L; Ruemmele FM; Griffiths A; Buderus S; Hradsky O; Hauer AC
    J Pediatr Gastroenterol Nutr; 2019 May; 68(5):676-683. PubMed ID: 30664566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
    Turner D; Huang Y; Martín-de-Carpi J; Aloi M; Focht G; Kang B; Zhou Y; Sanchez C; Kappelman MD; Uhlig HH; Pujol-Muncunill G; Ledder O; Lionetti P; Dias JA; Ruemmele FM; Russell RK;
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):727-733. PubMed ID: 32443020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?
    Tepeš K; Hanžel J; Štubljar D; Strmšek K; Erjavec L; Supovec E; Jagodic Z; Končan M; Grosek J; Košir JA; Tomažič A; Kogovšek U; Norčič G; Šibli R; Žnidaršič M; Pačnik Vižintin T; Sodin B; Breznik J; Hribar VA; Ocepek A; Pernat Drobež C; Bukovnik N; Zafošnik A; Marušič T; Jurečič Brglez N; Denkovski M; Smrekar N; Novak G; Koželj M; Kurent T; Simonič J; Pintar Š; Štabuc B; Drobne D
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):728-734. PubMed ID: 38625825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
    Lamb CA; Kennedy NA; Raine T; Hendy PA; Smith PJ; Limdi JK; Hayee B; Lomer MCE; Parkes GC; Selinger C; Barrett KJ; Davies RJ; Bennett C; Gittens S; Dunlop MG; Faiz O; Fraser A; Garrick V; Johnston PD; Parkes M; Sanderson J; Terry H; ; Gaya DR; Iqbal TH; Taylor SA; Smith M; Brookes M; Hansen R; Hawthorne AB
    Gut; 2019 Dec; 68(Suppl 3):s1-s106. PubMed ID: 31562236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance.
    Meijboom RW; Barbier L; Druedahl LC; Sarnola K; Tolonen HM; Gardarsdottir H; Egberts TCG; Giezen TJ
    Expert Opin Biol Ther; 2023; 23(8):801-817. PubMed ID: 36947408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current practice and perception of screening for medication adherence in inflammatory bowel disease.
    Trindade AJ; Morisky DE; Ehrlich AC; Tinsley A; Ullman TA
    J Clin Gastroenterol; 2011; 45(10):878-82. PubMed ID: 21555953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of inflammatory bowel disease among Canadian gastroenterologists.
    Jones J; Panaccione R; Russell ML; Hilsden R
    Can J Gastroenterol; 2011 Oct; 25(10):565-9. PubMed ID: 22059162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritization in inflammatory bowel disease therapy.
    Herrlinger KR; Stange EF
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):753-767. PubMed ID: 37480322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Disease in Childhood and Adolescence.
    Däbritz J; Gerner P; Enninger A; Claßen M; Radke M
    Dtsch Arztebl Int; 2017 May; 114(19):331-338. PubMed ID: 28597827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group.
    Arrigo S; Alvisi P; Banzato C; Bramuzzo M; Celano R; Civitelli F; D'Arcangelo G; Dilillo A; Dipasquale V; Felici E; Fuoti M; Gatti S; Knafelz D; Lionetti P; Mario F; Marseglia A; Martelossi S; Moretti C; Norsa L; Panceri R; Renzo S; Romano C; Romeo E; Strisciuglio C; Martinelli M
    Dig Liver Dis; 2021 Mar; 53(3):283-288. PubMed ID: 33388247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Uhlig HH; Charbit-Henrion F; Kotlarz D; Shouval DS; Schwerd T; Strisciuglio C; de Ridder L; van Limbergen J; Macchi M; Snapper SB; Ruemmele FM; Wilson DC; Travis SPL; Griffiths AM; Turner D; Klein C; Muise AM; Russell RK;
    J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):456-473. PubMed ID: 33346580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
    Klomberg RCW; Hellendoorn AE; Kemos P; Rizopoulos D; Ruemmele FM; Croft NM; de Ridder L;
    Lancet Child Adolesc Health; 2024 Jun; 8(6):422-432. PubMed ID: 38697175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management.
    Hibi T; Panaccione R; Katafuchi M; Yokoyama K; Watanabe K; Matsui T; Matsumoto T; Travis S; Suzuki Y
    J Crohns Colitis; 2017 Oct; 11(11):1302-1308. PubMed ID: 28981622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics.
    Devlin SM; Bressler B; Bernstein CN; Fedorak RN; Bitton A; Singh H; Feagan BG
    Can J Gastroenterol; 2013 Oct; 27(10):567-71. PubMed ID: 24106727
    [No Abstract]   [Full Text] [Related]  

  • 15. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
    Govani SM; Wiitala WL; Stidham RW; Saini SD; Hou JK; Feagins LA; Sussman JB; Higgins PD; Waljee AK
    Inflamm Bowel Dis; 2016 Aug; 22(8):1923-8. PubMed ID: 27416039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: recent developments.
    Ashton JJ; Beattie RM
    Arch Dis Child; 2024 Apr; 109(5):370-376. PubMed ID: 37468139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT).
    Fejrskov A; Füchtbauer JD; Davíðsdóttir LG; Halfvarson J; Høivik ML; Jensen MD; Mortensen JH; Nielsen LN; Rejler M; Repsilber D; Söderholm JD; Aalykke C; Andersen V; Christensen R; Kjeldsen J
    BMJ Open; 2024 May; 14(5):e083144. PubMed ID: 38754881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Kammermeier J; Lamb CA; Jones KDJ; Anderson CA; Baple EL; Bolton C; Braggins H; Coulter TI; Gilmour KC; Gregory V; Hambleton S; Hartley D; Hawthorne AB; Hearn S; Laurence A; Parkes M; Russell RK; Speight RA; Travis S; Wilson DC; Uhlig HH
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):271-286. PubMed ID: 36634696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute pancreatitis in children and adolescents: diagnostic and therapeutic approach according to management guidelines in a group of pediatricians.
    Peña-Vélez R; Dzul-Pech FM; Salgado-Valencia J; Calva R; Gil-Vargas M
    Bol Med Hosp Infant Mex; 2024; 81(2):85-89. PubMed ID: 38768511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study.
    Auth MK; Ashton JJ; Jones KDJ; Rodrigues A; Thangarajah D; Devadason D; Lee G; Ayaz M; Lee HM; Kammermeier J;
    Arch Dis Child; 2023 Dec; 108(12):994-998. PubMed ID: 37541682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.